These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 29120899)

  • 1. Association of a 3' untranslated region polymorphism in proprotein convertase subtilisin/kexin type 9 with HIV viral load and CD4+ levels in HIV/hepatitis C virus coinfected women.
    Kuniholm MH; Liang H; Anastos K; Gustafson D; Kassaye S; Nowicki M; Sha BE; Pawlowski EJ; Gange SJ; Aouizerat BE; Pushkarsky T; Bukrinsky MI; Prasad VR
    AIDS; 2017 Nov; 31(18):2483-2492. PubMed ID: 29120899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV and Hepatitis C-Coinfected Patients Have Lower Low-Density Lipoprotein Cholesterol Despite Higher Proprotein Convertase Subtilisin Kexin 9 (PCSK9): An Apparent "PCSK9-Lipid Paradox".
    Kohli P; Ganz P; Ma Y; Scherzer R; Hur S; Weigel B; Grunfeld C; Deeks S; Wasserman S; Scott R; Hsue PY
    J Am Heart Assoc; 2016 Apr; 5(5):. PubMed ID: 27130349
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatitis C virus and proprotein convertase subtilisin/kexin type 9: a detrimental interaction to increase viral infectivity and disrupt lipid metabolism.
    Pirro M; Bianconi V; Francisci D; Schiaroli E; Bagaglia F; Sahebkar A; Baldelli F
    J Cell Mol Med; 2017 Dec; 21(12):3150-3161. PubMed ID: 28722331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment-Induced Viral Cure of Hepatitis C Virus-Infected Patients Involves a Dynamic Interplay among three Important Molecular Players in Lipid Homeostasis: Circulating microRNA (miR)-24, miR-223, and Proprotein Convertase Subtilisin/Kexin Type 9.
    Hyrina A; Olmstead AD; Steven P; Krajden M; Tam E; Jean F
    EBioMedicine; 2017 Sep; 23():68-78. PubMed ID: 28864162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of antiretroviral therapy on proprotein convertase subtilisin/kexin 9: focus on lipids, inflammation and immunovirological parameters.
    Bianconi V; Schiaroli E; Pirro M; Cardaci S; Busti C; Mannarino MR; Baldelli F; Francisci D
    HIV Med; 2020 Sep; 21(8):512-522. PubMed ID: 32496664
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of incident hepatitis C infection on CD4+ cell count and HIV RNA trajectories based on a multinational HIV seroconversion cohort.
    van Santen DK; van der Helm JJ; Touloumi G; Pantazis N; Muga R; Gunsenheimer-Bartmeyer B; Gill MJ; Sanders E; Kelleher A; Zangerle R; Porter K; Prins M; Geskus RB;
    AIDS; 2019 Feb; 33(2):327-337. PubMed ID: 30325767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HCV Specific IL-21 Producing T Cells but Not IL-17A Producing T Cells Are Associated with HCV Viral Control in HIV/HCV Coinfection.
    MacParland SA; Fadel SM; Mihajlovic V; Fawaz A; Kim C; Rahman AK; Liu J; Kaul R; Kovacs C; Grebely J; Dore GJ; Wong DK; Ostrowski MA
    PLoS One; 2016; 11(4):e0154433. PubMed ID: 27124305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HCV-specific T-cell responses in HIV/hepatitis C virus-coinfected patients on highly active antiretroviral therapy are comparable to those observed in hepatitis C virus-monoinfected individuals.
    Rallón NI; Soriano V; Restrepo C; García-Samaniego J; Labarga P; López M; Peris A; González-Lahoz J; Benito JM
    J Acquir Immune Defic Syndr; 2011 May; 57(1):1-8. PubMed ID: 21786458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monocyte activation in HIV/HCV coinfection correlates with cognitive impairment.
    Rempel H; Sun B; Calosing C; Abadjian L; Monto A; Pulliam L
    PLoS One; 2013; 8(2):e55776. PubMed ID: 23437063
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dominant enrichment of phenotypically activated CD38(+) HLA-DR(+) CD8(+) T cells, rather than CD38(+) HLA-DR(+) CD4(+) T cells, in HIV/HCV coinfected patients on antiretroviral therapy.
    d'Ettorre G; Ceccarelli G; Serafino S; Giustini N; Cavallari EN; Bianchi L; Pavone P; Bellelli V; Turriziani O; Antonelli G; Stroffolini T; Vullo V
    J Med Virol; 2016 Aug; 88(8):1347-56. PubMed ID: 26765625
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proprotein Convertase Subtilisin/Kexin Type 9 Loss-of-Function Is Detrimental to the Juvenile Host With Septic Shock.
    Atreya MR; Whitacre BE; Cvijanovich NZ; Bigham MT; Thomas NJ; Schwarz AJ; Weiss SL; Fitzgerald JC; Allen GL; Lutfi R; Nowak JE; Quasney MW; Shah AS; Wong HR
    Crit Care Med; 2020 Oct; 48(10):1513-1520. PubMed ID: 32769621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the impact of hepatitis C virus (HCV) on highly active antiretroviral therapy-mediated immune responses in HCV/HIV-coinfected women: role of HCV on expression of primed/memory T cells.
    Al-Harthi L; Voris J; Du W; Wright D; Nowicki M; Frederick T; Landay A; Kovacs A
    J Infect Dis; 2006 May; 193(9):1202-10. PubMed ID: 16586355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of hepatitis C virus coinfection on T-cell dynamics in long-term HIV-suppressors under combined antiretroviral therapy.
    Zaegel-Faucher O; Bregigeon S; Cano CE; Obry-Roguet V; Nicolino-Brunet C; Tamalet C; Dignat-George F; Poizot-Martin I
    AIDS; 2015 Jul; 29(12):1505-10. PubMed ID: 26244390
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and predictors of low muscle mass in HIV/viral hepatitis coinfection.
    Gowda C; Brown TT; Compher C; Forde KA; Kostman J; Shaw PA; Tien PC; Lo Re V
    AIDS; 2016 Oct; 30(16):2519-2528. PubMed ID: 27490638
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toll-like receptor 8 (TLR8) polymorphisms are associated with non-progression of chronic hepatitis C in HIV/HCV coinfected patients.
    Fernández-Rodríguez A; Berenguer J; Jiménez-Sousa MA; García-Álvarez M; Aldámiz-Echevarría T; Pineda-Tenor D; Diez C; de la Barrera J; Bellon JM; Briz V; Resino S
    Infect Genet Evol; 2015 Dec; 36():339-344. PubMed ID: 26455634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proprotein convertase subtisilin/kexin 9 levels decline with hepatitis C virus therapy in people with HIV/hepatitis C virus and correlate with inflammation.
    Gandhi MM; Nguyen KL; Lake JE; Liao D; Khodabakhshian A; Guerrero M; Shufelt CL; Bairey Merz CN; Jordan WC; Daar ES; Bhattacharya D; Chew KW
    AIDS; 2024 Mar; 38(3):317-327. PubMed ID: 37788081
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of Genetic Polymorphisms of Tumor Necrosis Factor Alpha and Interleukin 10 Genes on the Risk of Liver Cirrhosis in HIV-HCV Coinfected Patients.
    Corchado S; Márquez M; Montes de Oca M; Romero-Cores P; Fernández-Gutiérrez C; Girón-González JA
    PLoS One; 2013; 8(6):e66619. PubMed ID: 23840511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of lymphoma in HIV-HCV-infected patients. Modifications in function of the anti-hepatitis C virus therapy.
    Gutiérrez-Saborido D; Gutiérrez-Valencia A; González Domenech CM; López Ruz MÁ; Raffo Márquez M; Omar M; Girón-González JA;
    Ann Hematol; 2019 Aug; 98(8):1953-1959. PubMed ID: 31025161
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Hepatitis C Virus on the Circulating Levels of IL-7 in HIV-1 Coinfected Women.
    Kerzerho J; McIlvaine EJ; Anthony P; Mack WJ; Wang CH; Frederick T; Operskalski E; Chen Z; Al-Harthi L; Landay A; Young MA; Tien PC; Augenbraun M; Strickler HD; Akbari O; Golub ET; Sharp GB; Kovacs A
    J Acquir Immune Defic Syndr; 2016 Feb; 71(2):172-80. PubMed ID: 26761519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclase-associated protein 1 is a binding partner of proprotein convertase subtilisin/kexin type-9 and is required for the degradation of low-density lipoprotein receptors by proprotein convertase subtilisin/kexin type-9.
    Jang HD; Lee SE; Yang J; Lee HC; Shin D; Lee H; Lee J; Jin S; Kim S; Lee SJ; You J; Park HW; Nam KY; Lee SH; Park SW; Kim JS; Kim SY; Kwon YW; Kwak SH; Yang HM; Kim HS
    Eur Heart J; 2020 Jan; 41(2):239-252. PubMed ID: 31419281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.